No abstract available
MeSH terms
-
Acetylgalactosamine / therapeutic use*
-
Adolescent
-
Adult
-
Antibodies, Bispecific / adverse effects*
-
Antibodies, Bispecific / therapeutic use
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Blood Coagulation Factors / adverse effects*
-
Blood Coagulation Factors / therapeutic use
-
Congresses as Topic
-
Factor VIIa / adverse effects*
-
Factor VIIa / therapeutic use
-
Hemophilia A / blood
-
Hemophilia A / therapy*
-
Hemophilia B / blood
-
Hemophilia B / therapy*
-
Hemorrhage / blood
-
Hemorrhage / therapy
-
Humans
-
RNA, Small Interfering / therapeutic use*
-
Recombinant Proteins / adverse effects
-
Recombinant Proteins / therapeutic use
-
Thromboembolism / chemically induced*
Substances
-
Antibodies, Bispecific
-
Antibodies, Monoclonal, Humanized
-
Blood Coagulation Factors
-
RNA, Small Interfering
-
Recombinant Proteins
-
fitusiran
-
prothrombin complex concentrates
-
emicizumab
-
recombinant FVIIa
-
Factor VIIa
-
Acetylgalactosamine